| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2010-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bab486dae78d08150d8dcda655259837
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e05cff4f4a0f244476331a5850816ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5ba0920deebc8981e548557acf207d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a50850eec723f9fbcc0fde70f64736e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faf5e701ae074380cfa117abbbabce64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41c8d57cf9cb66a2875142b29562e8fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad26a836695faefe4a9c7f95c82b671e |
| publicationDate |
2017-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MY-160665-A |
| titleOfInvention |
Spiropiperidine compounds as orl-1 receptor antagonists |
| abstract |
AN ORL-1 RECEPTOR ANTAGONIST OF THE FORMULA: ITS USES, AND METHODS FOR ITS PREPARATION ARE DESCRIBED. |
| priorityDate |
2009-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |